Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Kucukcekmece, 34303, Turkey (Türkiye)
NCT Number: NCT03166826
Apgar scoring system has been widely used for the evaluation of the infant's postnatal condition. As conventional Apgar scoring system is affected by gestational age and resuscitative efforts, there is a need for development of new scoring systems for the assessment in the delivery room. Herein, Modified Combined Apgar scoring system which includes two new parameters (cord blood pH and targeted oxygen saturation level) has been developed and the utility of this modified system was compared with Conventional and Combined Apgar scoring systems for prediction of hospitalization.
Looking for future studies?
Notify MeUp to 2 hour
All sexes
Observational
Istanbul, Kucukcekmece, 34303, Turkey (Türkiye)
This is a prospective cohort study. Conventional, Combined and Modified Combined Apgar scores at minutes 1 and 5 are all recorded. For Modified scoring system, blood sample is obtained from the umbilical artery and pulse oximetry is used for measurement of oxygen saturation. Prediction of NICU hospitalization is used as a surrogate parameter to compare the scores.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Term neonates Preterm neonates Parental approval
Exclusion criteria
Major congenital/chromosomal abnormalities Lack of informed consent Stillbirth Outborn infants
Modified APGAR scoring system
Time frame: 10 months
The predictive value of Modified Combined Apgar scoring for hospitalization of infants
Kanuni Sultan Suleyman Training and Research Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05451953
Neonatal Respiratory Failure, Tracheal Intubation Morbidity
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05036603
Atelectasis Neonatal, Bronchopulmonary Dysplasia
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT05508308
Female Urogenital Diseases and Pregnancy Complications, Neonatal Respiratory Distress Related Conditions
Lantoro, Abeokuta, Nigeria
View Trial DetailsNCT03154112
Cardiovascular Abnormalities, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial Details